Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate ICON Public Limited Company before investing.
In this article, we go over a few key elements for understanding ICON Public Limited Company’s stock price such as:
- ICON Public Limited Company’s current stock price and volume
- Why ICON Public Limited Company’s stock price changed recently
- Upgrades and downgrades for ICLR from analysts
- ICLR’s stock price momentum as measured by its relative strength
About ICON Public Limited Company (ICLR)
Before we jump into ICON Public Limited Company’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Want to learn more about ICON Public Limited Company’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about ICON Public Limited Company.
ICON Public Limited Company’s Stock Price as of Market Close
As of May 08, 2026, 10:47 AM, CST, ICON Public Limited Company’s stock price was $123.045.
ICON Public Limited Company is down 1.56% from its previous closing price of $125.000.
During the last market session, ICON Public Limited Company’s stock traded between $120.340 and $128.950. Currently, there are approximately 77.37 million shares outstanding for ICON Public Limited Company.
ICON Public Limited Company’s price-earnings (P/E) ratio is currently at 16.7, which is low compared to the Life Sciences Tools & Services industry median of 32.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.
ICON Public Limited Company Stock Price History
ICON Public Limited Company’s (ICLR) price is currently up 3.98% so far this month.
During the month of May, ICON Public Limited Company’s stock price has reached a high of $129.730 and a low of $108.796.
Over the last year, ICON Public Limited Company has hit prices as high as $211.000 and as low as $66.570. Year to date, ICON Public Limited Company’s stock is down 32.47%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused ICON Public Limited Company Stock’s Price to Dip?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 07, 2026, there were 0 analysts who downgraded ICON Public Limited Company’s stock and 1 analyst who upgraded over the last month.
Additionally, you'll want to evaluate ICON Public Limited Company’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on ICON Public Limited Company’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
ICON Public Limited Company’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about ICON Public Limited Company (ICLR) by visiting AAII Stock Evaluator.
Relative Price Strength of ICON Public Limited Company
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of May 07, 2026, ICON Public Limited Company has a weighted four-quarter relative price strength of -11.10%, which translates to a Momentum Score of 22 and is considered to be Weak.
Want to learn more about how ICON Public Limited Company is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
ICON Public Limited Company Stock Price: Bottom Line
As of May 8, 2026, ICON Public Limited Company’s stock price is $123.045, which is down 1.56% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like ICON Public Limited Company stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
at only 6.9%
Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.